Treatment pattern and adverse effects of antiseizure medications among adult patients with epilepsy: A single centre observational cross-sectional study in Northern Sri Lanka
Preprint
- 2 December 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Antiseizure medications (ASMs) are essential for seizure control, but they are also associated with a range of adverse effects that may affect treatment outcomes. Objective: This study aimed to evaluate the treatment pattern and adverse effects of ASMs among adult patients with epilepsy who were followed up at a tertiary-care hospital in Northern Sri Lanka. Methods: A descriptive cross-sectional study was conducted among adult patients on ASMs for ≥3 months who were receiving follow-up at Teaching Hospital Jaffna. Data were collected over four months using a pretested interviewer-administered questionnaire. Chi-square test and logistic regression were performed to determine the significance between groups and the association of independent variables, respectively. A p-value of ≤0.05 was considered statistically significant. Results: Data from 213 participants was analysed. The mean age was 36.27 ± 0.92 years, and the male-to-female ratio was almost 1. Nearly two-thirds of participants (64.8%) were on dual or polytherapy. Older ASMs were predominantly prescribed (74.5%). A total of 333 adverse effects were reported, giving a point prevalence of 68.5% and a rate of 1.6 adverse effects per person. Sedation (27%), memory impairment (24%), and dizziness (21%) were the most common adverse effects. Advancing age (adjusted OR (AOR): 4.3, 95% CI 1.87 to 10.29, p<0.001), early onset of epilepsy (AOR: 0.35, 95% CI 0.14 to 0.87, p=0.023), and the use of multiple ASMs (AOR: 2.7, 95% CI 1.4 to 5.3, p=0.003) were associated with the occurrence of adverse effects. Carbamazepine, clobazam and valproic acid were significantly (p<0.05) associated with one or more common adverse effects. Conclusion: Most patients in this study received older antiseizure medications and polytherapy. A high burden of medication-related adverse effects was also observed. Regular review and reconciliation of treatment and improving access to better-tolerated medication would reduce the medication-related burden among patients with epilepsy.Keywords
All Related Versions
- Version 1, 2025-12-02, Research Square
- Published version: BMC Neurology, 26.
This publication has 20 references indexed in Scilit:
- Predictors of adverse effects to antiseizure drugs in adult patients with epilepsy from Colombia: A case–control studyEpilepsy & Behavior, 2023
- Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with EpilepsyCNS Drugs, 2023
- The burden of epilepsy and unmet need in people with focal seizuresBrain and Behavior, 2022
- Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019Epilepsy & Behavior, 2022
- The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and BeyondCNS Drugs, 2021
- 30 years of second-generation antiseizure medications: impact and future perspectivesThe Lancet Neurology, 2020
- Age, sex and ethnic differentials in the prevalence and control of epilepsy among Sri Lankan children: a population-based studyBMJ Paediatrics Open, 2019
- Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events ProfileNeurology Research International, 2018
- An evaluation of factors affecting adherence to antiepileptic drugs in patients with epilepsy: a cross-sectional studySingapore Medical Journal, 2017
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000